NEOGENOMICS INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Neogenomics Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2013 to Q3 2024.
  • Neogenomics Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$150K, a 94.9% increase year-over-year.
  • Neogenomics Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$2.11M, a 80.9% increase year-over-year.
  • Neogenomics Inc annual Income Tax Expense (Benefit) for 2023 was -$9.13M, a 39.5% increase from 2022.
  • Neogenomics Inc annual Income Tax Expense (Benefit) for 2022 was -$15.1M, a 124% decline from 2021.
  • Neogenomics Inc annual Income Tax Expense (Benefit) for 2021 was -$6.73M, a 63.1% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.11M -$150K +$2.79M +94.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$4.89M -$375K +$1.93M +83.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 -$6.82M -$620K +$2.31M +78.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 -$9.13M -$960K +$1.88M +66.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$11M -$2.94M -$163K -5.88% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$10.8M -$2.31M +$3.42M +59.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$14.3M -$2.93M +$828K +22.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 -$15.1M -$2.84M -$392K -16% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$14.7M -$2.77M +$50K +1.77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$14.8M -$5.73M -$3.29M -135% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$11.5M -$3.75M -$4.73M -485% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$6.73M -$2.45M +$5.41M +68.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$12.1M -$2.82M -$2.49M -742% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$9.65M -$2.44M +$8.7M +78.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$18.3M $976K -$113K -10.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$18.2M -$7.85M -$3.99M -103% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 -$14.2M -$335K -$1.68M -125% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$12.6M -$11.1M -$11.3M -6461% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$1.25M $1.09M +$3.11M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$4.36M -$3.86M -$4.91M -468% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $549K $1.35M +$1.29M +2396% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$745K $175K +$532K Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$1.28M -$2.02M -$2.46M -562% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $1.18M $1.05M +$3.27M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$2.09M $54K -$748K -93.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$1.34M -$357K -$304K -574% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.04M $438K +$1.22M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$2.25M -$2.22M -$23K -1.05% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$2.23M $802K +$808K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$3.04M -$53K -$385K -116% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$2.65M -$779K -$953K -548% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$1.7M -$2.2M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 -$6K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $332K +$317K +2113% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $174K +$169K +3380% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q2 2015 $15K -$36K -70.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $5K -$22K -81.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q2 2014 $51K Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $27K +$10K +58.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 $29K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q1 2013 $17K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.